openPR Logo
Press release

Vascular Stent Market Segmentation, Trends, Growth, Overview, Share Analysis, 2033

Vascular Stent Market Overview

Vascular Stent Market Overview

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Vascular Stent Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $23.61 billion In 2028 At A CAGR Of 9.8% :

The vascular stent market size has grown rapidly in recent years. It will grow from $14.74 billion in 2023 to $16.26 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to clinical research and development, drug-eluting stents (des), introduction of balloon angioplasty, early stent innovations, physician training and skill development.

The vascular stent market size is expected to see strong growth in the next few years. It will grow to $23.61 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to focus on preventive cardiovascular care, shift towards outpatient procedures, cost-effectiveness and value-based healthcare, bioabsorbable stents and next-generation materials, expansion of endovascular interventions. Major trends in the forecast period include advancements in stent coatings and materials, patient education and awareness, shift towards outpatient settings, focus on cost-effectiveness.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Vascular Stent Market Major Segments
The vascular stent market covered in this report is segmented -

1) By Product: Coronary Stents, Peripheral Vascular Stents, Evar Stent Grafts
2) By Type: Bare Metal Stent, Bio-engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent
3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents
4) By Mode of Delivery: Balloon-expandable Stent, Self-expanding Stent
5) By End-user: Ambulatory Surgical Center, Cardiac Center, Hospital

Key Driver - Navigating Cardiovascular Health Surge In Vascular Diseases Propels Growth Of The Vascular Stent Market

Rise in the incidence of vascular diseases will propel the growth of the vascular stent market going forward. Vascular disease refers to an abnormal condition that affects the blood vessels (arteries and veins) and is part of the cardiovascular diseases (CVD) group. Vascular stents help in the treatment of various vascular diseases by enabling the supply of oxygen-rich blood to the heart. For instance, in May 2023, according to the Center for Disease Control and Prevention, a US-based federal agency for national public health, about 695,000 people in the United States died from heart disease in 2021, that's 1 in every 5 deaths. Therefore, an increase in cardiovascular diseases (CVDs) will drive the growth of the vascular stent market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=8363&type=smp

Prominent Trend - Translumina's Vivo Isar Sets The Pace In The Technologically Advanced Vascular Stent Market

Technological advancement is a key trend gaining popularity in the vascular stent market. Many companies are investing in bio-sensing devices, cutting-edge integrated stents, and drug-eluting coronary stent systems to gain a competitive edge in the market. For instance, in 2022, Translumina, an India-based medical equipment manufacturer launched VIVO ISAR, a latest generation dual drug polymer-free coated stent (DDCS) that brings together a stent with a superior safety profile without compromising the drug release kinetics. It uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenosis drug), and thus creates a polymer-free DES platform with uncompromised safety and efficacy.

Vascular Stent Market Players
Major companies operating in the vascular stent market report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., Lombard Medical Technologies Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology (Beijing) Co. Ltd., Koninklijke Philips N.V., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Stryker Corporation, Osypka AG, Spectranetics Corporation, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., Siemens Healthineers AG, General Electric Company, Nihon Kohden Corporation, Fujifilm Corporation, EP Medsystems Inc., ZOLL Medical Corporation

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the vascular stent market share in 2023. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Vascular Stent Market Report Structure
3. Vascular Stent Market Trends And Strategies
4. Vascular Stent Market - Macro Economic Scenario
5. Vascular Stent Market Size And Growth
…..
27. Vascular Stent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vascular Stent Market Segmentation, Trends, Growth, Overview, Share Analysis, 2033 here

News-ID: 3541579 • Views:

More Releases from The Business research company

Natural & Breathable Dog Beds Drive Innovation in the Sustainable Pet Beds Market
Natural & Breathable Dog Beds Drive Innovation in the Sustainable Pet Beds Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Sustainable Pet Beds Industry Market Size Be by 2025? The sustainable pet beds market has experienced strong growth in recent years. It will expand from $2.34 billion in 2024 to $2.5 billion in 2025, reflecting a CAGR of 6.8%. What's the Long-Term Growth Forecast for the Sustainable
Driving Smart Polymers Market Growth in 2025: The Role of The Impact Of Automotive Industry Growth On The Smart Polymer Market
Driving Smart Polymers Market Growth in 2025: The Role of The Impact Of Automoti …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Smart Polymers Market Size Growth Forecast: What to Expect by 2025? The smart polymers market has witnessed rapid growth in recent years. It is projected to move from $5.41 billion in 2024 to $6.1 billion in 2025, recording a CAGR of 12.7%. How Will the Smart Polymers Market Size Evolve
Top Market Shifts Transforming the Rainwear Market Landscape: Key Insights
Top Market Shifts Transforming the Rainwear Market Landscape: Key Insights
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Rainwear Market Through 2025? The rainwear market has seen strong growth in recent years. It is forecast to increase from $3.47 billion in 2024 to $3.67 billion in 2025, at a CAGR of 5.7%. Growth historically was influenced by more frequent heavy
Plant-Based Food Packaging Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Plant-Based Food Packaging Market Landscape to 2034: Key Forces Shaping the Next …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Plant-Based Food Packaging Market Size By 2025? The plant-based food packaging market has grown rapidly in recent years. It is projected to rise from $6.39 billion in 2024 to $7.2 billion in 2025 at a CAGR of 12.6%. Historic growth was fueled by rising environmental

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients